Revenue by Segment

Financials in millions CNY. Fiscal year is April - March.

Millions CNY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Development, Production, Marketing and Sale of Biopharmaceutical Products	614.96M	573.42M	687.20M	502.95M	257.02M
Development, Production, Marketing and Sale of Biopharmaceutical Products Growth	7.24%	-16.56%	36.63%	95.69%	-
Total	614.96M	573.42M	687.20M	502.95M	257.02M
Total Growth	7.24%	-16.56%	36.63%	95.69%	-

Source: S&P Global Market Intelligence.